Effects of Amino Acids on Regional Lipid Metabolism
Completed · Not applicable · Has a placebo group
Conditions studied: Hypertriglyceridemia
In brief
Elevated fat level in blood is a risk factor for coronary heart disease, a major cause of death in America. The overall goal of this project is to test a novel treatment using nutrient (amino acid) supplementation against this condition in men and women, and to understand how this treatment works.
Key facts
- Study ID
- NCT01150188
- Run by
- University of Arkansas
- People needed
- 125
- Starts
- 2010-06-01
- Expected to finish
- 2016-08-01
- Last updated by the study team
- 2016-10-27
Who can join
Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 50-75 years.
- Men and Women (Women postmenopausal).
- Ability to sign informed consent, including ≥26 Mini-Mental State Exam.
- Plasma triglyceride concentration between 130-500 mg/dl.
You may not qualify if…
- Diabetes (plasma glucose: fasting ≥126 mg/dl or ≥200 mg/dl at 2 hr after 75 g glucose load).
- On diabetes medication or lipid altering agents, including over the counter fish oil/omega 3 fatty acids.
- Kidney/renal or liver disease.
- Bleeding disorders or anemia.
- Endocrine disease.
- Positive hepatitis or HIV screens.
- Alcohol abuse or drug abuse
- Score of <26 on the Mini-Mental State Exam.
- Allergy to iodine or fish products.
- Subjects with cerebral aneurysm clips, internal transistorized devices (e.g., neural stimulators), or cardiac pacemakers.
Where it is running
- University of Arkansas for Medical Science, Reynolds Aging Institute — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.